The combined use of transmyocardial laser revascularization (TMLR) and fibroblastic growth factor (FGF-2) enhances perfusion and regional contractility in chronically ischemic porcine hearts

European Journal of Cardio-thoracic Surgery

Volumn 22, Issue 5, 2002, Pages 753-761

  Lutter, Georg ^a   Attmann, Tim ^a   Heilmann, Claudia ^a   Von Samson, Patrick ^a   Von Specht, Bernd ^a   Beyersdorf, Friedhelm ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Angiogenesis; Arteriogenesis; Contractility; Coronary disease; Growth factors; Perfusion; Transmyocardial laser revascularization

Indexed keywords

RECOMBINANT FIBROBLAST GROWTH FACTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; IMMUNOHISTOCHEMISTRY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NONHUMAN; PRIORITY JOURNAL; STRESS; TREATMENT OUTCOME;

ANIMALS; ARTERIOLES; CAPILLARIES; COMBINED MODALITY THERAPY; CORONARY CIRCULATION; FIBROBLAST GROWTH FACTOR 2; LASER SURGERY; MICROSPHERES; MYOCARDIAL CONTRACTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REVASCULARIZATION; NEOVASCULARIZATION, PHYSIOLOGIC; RECOMBINANT PROTEINS; SWINE;

EID: 0036843674     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1010-7940(02)00527-4     Document Type: Conference Paper

References (23)

1. Mirhoseini M., Shelgikar S., Cayton M.M. New concepts in revascularization of the myocardium. Ann Thorac Surg. 45:1988;415-420.
2. Frazier O.H., March R.J., Horvath K.A. Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease. N Engl J Med. 341:1999;1021-1028.
3. Lutter G., Yoshitake M., Takahashi N., Nitzsche E., Martin J., Sarai K., Lutz C., Beyersdorf F. Transmyocardial laser - revascularization: experimental studies on prolonged acute regional ischemia. Eur J Cardiothorac Surg. 13:1998;694-701.
4. Lutter G., Martin J., Dern P., Sarai K., v.Samson P., Buerkle M., v.Specht B., Beyersdorf F. Evaluation of the indirect revascularization method after 3 months chronic ischemia. Eur J Cardiothorac Surg. 18:2000;38-45.
5. Bridges C.R. Myocardial laser revascularization: the controversy and the data. Ann Thorac Surg. 69:2000;655-662.
6. 2, and excimer lasers. Ann Thorac Surg. 70:2000;504-509.
7. Krabatsch T., Schaper F., Leder C., Tulsner J., Thalmann U., Hetzer R. Histological findings after transmyocardial laser revascularization. J Card Surg. 11:1996;326-331.
8. Lutter G., Schwarzkopf J., Lutz C., Martin J., Beyersdorf F. Histologic findings of transmyocardial laser channels after 2 h. Ann Thorac Surg. 65:1998;1437-1439.
9. Klagsbrun M. The fibroblastic growth factor family: structural and biological properties. Prog Growth Factor Res. 1:1989;207-235.
10. Schaper W., Sharma H.S., Quinkler W., Markert T., Wünsch M., Schaper J. Molecular biologic concepts of coronary anastomoses. J Am Coll Cardiol. 15:1990;513-518.
11. Schumacher B., Pecher P., von Specht B.U., Stegmann T. Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease. Circulation. 97:(7):1998;645-650.
12. Lutter G., Martin J., von Samson P., Heilmann C., Sarai K., Beyersdorf F. Microperfusion enhancement after TMLR in chronically ischemic porcine hearts. Cardiovasc Surg. 9:2001;281-291.
13. Chen C., Chen L., Fallon J.T., Ma L., Li L., Bow L., Knibbs D., McKay R., Gillam L.D., Waters D.D. Functional and structural alterations with 24-h myocardial hibernation and recovery after reperfusion. A pig model of myocardial hibernation. Circulation. 94:1996;507-516.
14. Kowallik P., Schulz R., Guth B.D., Schade A., Paffhausen W., Gross R., Heusch G. Measurement of regional myocardial blood with multiple colored microspheres. Circulation. 83:1991;974-982.
15. Fallavollita J.A., Logue M., Canty J.M. Jr. Stability of hibernating myocardium in pigs with a chronic left anterior descending coronary artery stenosis: absence of progressive fibrosis in the setting of stable reductions in flow, function and coronary flow reserve. J Am Coll Cardiol. 37:2001;1989-1995.
16. Harada K., Grossman W., Friedman M., Edelman E.R., Prasad P.V., Keighley C.S., Manning W., Sellke F., Simons M. Basic fibroblastic growth factor improves myocardial function in chronically ischemic porcine hearts. J Clin Invest. 94:1994;623-630.
17. Mirhoseini M., Cayton M.M. Transmyocardial laser revascularization: historical background and future directions. J Clin Laser Med Surg. 15:1997;245-253.
18. Mueller X.M., Tevaearai H.T., Genton C.Y., Chaubert P., von Segesser L.K. Are there vascular density gradients along myocardial laser channels? Ann Thorac Surg. 68:1999;125-130.
19. Lutter G., Schwarzkopf J., Takahashi N., Yoshitake M., Nitzsche E., Martin J., Beyersdorf F. Transmyocardial laser revascularization: experimental studies in healthy porcine myocardium. Ann Thorac Surg. 67:1999;1708-1713.
20. Yanagisawa-Miwa A., Uchida Y., Nakamura F., Tomaru T., Kido H., Kamijo T., Sugimoto T., Kaji K., Utsuyama M., Kurashima C., Ito H. Salvage of infarcted myocardium by angiogenic action of basic fibroblastic growth factor. Science. 257:1992;1401-1402.
21. Laham R.J., Sellke F.W., Edelman E.R., Pearlman J.D., Ware J.A., Brown D.L., Gold J.P., Simons M. Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery. Circulation. 100:1999;1865-1871.
22. Yamamoto N., Kohmoto T., Roethy W., Gu A., DeRosa C., Rabbani L.E., Smith C.R., Burkhoff D. Histologic evidence that basic fibroblast growth factor enhances the angiogenic effects of transmyocardial laser revascularization. Basic Res Cardiol. 95:(1):2000;55-63.
23. Sayeed-Shah U., Mann M.J., Martin J., Grachev S., Reimold S., Laurence R., Dzau V., Cohn L.H. Complete reversal of ischemic wall motion abnormalities by combined use of gene therapy with transmyocardial laser revascularization. J Thorac Cardiovasc Surg. 116:1998;763-769.